224 related articles for article (PubMed ID: 18700173)
21. Increased percentages of autoantibodies in immunoglobulin A-deficient children do not correlate with clinical manifestations.
Gulez N; Karaca NE; Aksu G; Kutukculer N
Autoimmunity; 2009 Jan; 42(1):74-9. PubMed ID: 19127458
[TBL] [Abstract][Full Text] [Related]
22. The frequency of anti-beta2-glycoprotein I antibodies is low and these antibodies are associated with pulmonary hypertension in mixed connective tissue disease.
Hasegawa EM; Caleiro MT; Fuller R; Carvalho JF
Lupus; 2009 Jun; 18(7):618-21. PubMed ID: 19433462
[TBL] [Abstract][Full Text] [Related]
23. Mild depressive symptoms are associated with amplified and prolonged inflammatory responses after influenza virus vaccination in older adults.
Glaser R; Robles TF; Sheridan J; Malarkey WB; Kiecolt-Glaser JK
Arch Gen Psychiatry; 2003 Oct; 60(10):1009-14. PubMed ID: 14557146
[TBL] [Abstract][Full Text] [Related]
24. Differences in anti-phosphatidylserine-prothrombin complex antibodies and cutaneous vasculitis between regular livedo reticularis and livedo racemosa.
Kawakami T; Yamazaki M; Mizoguchi M; Soma Y
Rheumatology (Oxford); 2009 May; 48(5):508-12. PubMed ID: 19273539
[TBL] [Abstract][Full Text] [Related]
25. Intradermal influenza vaccination in immunocompromized patients is immunogenic and feasible.
Gelinck LB; van den Bemt BJ; Marijt WA; van der Bijl AE; Visser LG; Cats HA; Rimmelzwaan GF; Kroon FP
Vaccine; 2009 Apr; 27(18):2469-74. PubMed ID: 19368788
[TBL] [Abstract][Full Text] [Related]
26. The Risk of Autoimmunity Development following mRNA COVID-19 Vaccination.
Świerkot J; Madej M; Szmyrka M; Korman L; Sokolik R; Andrasiak I; Morgiel E; Sebastian A
Viruses; 2022 Nov; 14(12):. PubMed ID: 36560659
[TBL] [Abstract][Full Text] [Related]
27. Diluted Russell viper-venom time improves identification of antiphospholipid syndrome in a lupus anticoagulant-positive patient population.
Lambert M; Ferrard-Sasson G; Dubucquoi S; Hachulla E; Prin L; Hatron PY; Goudemand J; Boffa MC; Caron C
Thromb Haemost; 2009 Mar; 101(3):577-81. PubMed ID: 19277423
[TBL] [Abstract][Full Text] [Related]
28. Safety and efficacy of a novel microneedle device for dose sparing intradermal influenza vaccination in healthy adults.
Van Damme P; Oosterhuis-Kafeja F; Van der Wielen M; Almagor Y; Sharon O; Levin Y
Vaccine; 2009 Jan; 27(3):454-9. PubMed ID: 19022318
[TBL] [Abstract][Full Text] [Related]
29. Effect of a second, booster, influenza vaccination on antibody responses in quiescent systemic lupus erythematosus: an open, prospective, controlled study.
Holvast A; van Assen S; de Haan A; Huckriede A; Benne CA; Westra J; Palache A; Wilschut J; Kallenberg CG; Bijl M
Rheumatology (Oxford); 2009 Oct; 48(10):1294-9. PubMed ID: 19692457
[TBL] [Abstract][Full Text] [Related]
30. Safety and efficiency of influenza vaccination in systemic lupus erythematosus patients.
Wallin L; Quintilio W; Locatelli F; Cassel A; Silva MB; Skare TL
Acta Reumatol Port; 2009; 34(3):498-502. PubMed ID: 19820674
[TBL] [Abstract][Full Text] [Related]
31. Are anti-beta-glycoprotein-I antibodies markers for recurrent pregnancy loss in lupus anticoagulant/anticardiolipin seronegative women?
Alijotas-Reig J; Casellas-Caro M; Ferrer-Oliveras R; Llurba-Olive E; Hermosilla E; Vilardell-Tarres M; Cabero-Roura L
Am J Reprod Immunol; 2008 Sep; 60(3):229-37. PubMed ID: 18782284
[TBL] [Abstract][Full Text] [Related]
32. Long-lasting immunogenicity of a virosomal vaccine in older children and young adults with type I diabetes mellitus.
Zuccotti GV; Scaramuzza A; Riboni S; Mameli C; Pariani E; Tanzi E; Zanetti A; Radaelli G
Vaccine; 2009 Aug; 27(39):5357-62. PubMed ID: 19607951
[TBL] [Abstract][Full Text] [Related]
33. Influenza vaccination in patients with cirrhosis and in liver transplant recipients.
Gaeta GB; Pariani E; Amendola A; Brancaccio G; Cuomo G; Stornaiuolo G; Zappa A; Zanetti A
Vaccine; 2009 May; 27(25-26):3373-5. PubMed ID: 19200844
[TBL] [Abstract][Full Text] [Related]
34. Anticardiolipin and antinuclear antibodies in epilepsy--a population-based cross-sectional study.
Ranua J; Luoma K; Peltola J; Haapala AM; Raitanen J; Auvinen A; Isojärvi J
Epilepsy Res; 2004 Jan; 58(1):13-8. PubMed ID: 15066670
[TBL] [Abstract][Full Text] [Related]
35. Vaccination of healthy subjects and autoantibodies: from mice through dogs to humans.
Toplak N; Avcin T
Lupus; 2009 Nov; 18(13):1186-91. PubMed ID: 19880566
[TBL] [Abstract][Full Text] [Related]
36. Concentration of antibodies to extractable nuclear antigens and disease activity in systemic lupus erythematosus.
Agarwal S; Harper J; Kiely PD
Lupus; 2009 Apr; 18(5):407-12. PubMed ID: 19318392
[TBL] [Abstract][Full Text] [Related]
37. Antibody response to influenza vaccine in coronary artery disease: a substudy of the FLUCAD study.
Brydak LB; Romanowska M; Nowak I; Ciszewski A; Bilińska ZT
Med Sci Monit; 2009 Jul; 15(7):PH85-91. PubMed ID: 19564837
[TBL] [Abstract][Full Text] [Related]
38. Influenza vaccination among adults with asthma findings from the 2007 BRFSS survey.
Lu PJ; Euler GL; Callahan DB
Am J Prev Med; 2009 Aug; 37(2):109-15. PubMed ID: 19589448
[TBL] [Abstract][Full Text] [Related]
39. Evaluation of the BioPlex 2200 ANA screen for the detection of antinuclear antibodies and comparison with conventional methods.
Desplat-Jego S; Bardin N; Larida B; Sanmarco M
Ann N Y Acad Sci; 2007 Aug; 1109():245-55. PubMed ID: 17785313
[TBL] [Abstract][Full Text] [Related]
40. Influenza vaccination in the United States, 2005-2007.
Merrill RM; Beard JD
Med Sci Monit; 2009 Jul; 15(7):PH92-100. PubMed ID: 19564838
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
